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Abstract
Background Morbidly obese patients are at high risk to
develop gallstones, and rapid weight loss after bariatric
surgery further enhances this risk. The concept of prophy-
lactic cholecystectomy during gastric bypass has been
challenged recently because the risk may be lower than
reported earlier and because cholecystectomy during lapa-
roscopic gastric bypass may be more difficult and risky.
Methods A review of prospectively collected data on 772
patients who underwent laparoscopic primary gastric bypass
between January 2000 and August 2007 was performed. The
charts of patients operated before 2004 were retrospectively
reviewed regarding preoperative echography and histo-
pathological findings.
Results Fifty-eight (7.5%) patients had had previous chole-
cystectomy. In the remaining patients, echography showed
gallstones or sludge in 81 (11.3%). Cholecystectomy was
performed at the time of gastric bypass in 665 patients
(91.7%). Gallstones were found intraoperatively in 25
patients (3.9%), for a total prevalence of gallstones of
21.2%. The age of patients with gallstones was higher than
that of gallstone-free patients (43.5 vs 38.7 years, p<0.0001).
Of the removed specimens, 81.8% showed abnormal
histologic findings, mainly chronic cholecystitis and cho-
lesterolosis. Cholecystectomy was associated with no
procedure-related complication, prolonged duration of
surgery by a mean of 19 min (4–45), and had no effect on
the duration of hospital stay. Cholecystectomy was deemed
too risky in 59 patients (8.3%) who were prescribed a
6-month course of ursodeoxycolic acid.
Conclusion Concomitant cholecystectomy can be performed
safely in most patients during laparoscopic gastric bypass and
does not prolong hospital stay. As such, it is an acceptable form
of prophylaxis against stones forming during rapid weight
loss. Whether it is superior to chemical prophylaxis remains to
be demonstrated in a large prospective randomized study.
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Introduction
The prevalence of obesity is increasing almost exponentially
worldwide, resulting in an enormous rise in the number of
bariatric procedures performed each year. In the severely
obese patients, cholesterol secretion by the liver is increased.
This results in an increased cholesterol concentration in the
bile without a proportional increase in phospholipids and bile
salts [1, 2], which makes it difficult to maintain the cho-
lesterol in solution. Obese patients also have a larger
gallbladder with a reduced contractility [3]. These different
mechanisms are responsible for an increased prevalence of
gallstones in obese patients. Numerous studies have shown
that the prevalence of gallbladder pathology, and especially
gallstones, is three to five times higher in obese patients
compared with the general population [1, 2, 4–11]. Weight
loss associated with low-calorie diet, and especially rapid
weight loss that follows bariatric surgery, further enhances
the lithogenicity of the bile by increasing cholesterol
secretion even more. Some bariatric procedures like Roux-
en-Y gastric bypass (RYGBP) reduce the post-prandial level
OBES SURG (2008) 18:535–539
DOI 10.1007/s11695-007-9368-8
A. Nougou :M. Suter (*)
Department of Surgery, Hôpital du Chablais,
Aigle-Monthey, Switzerland
e-mail: michelsuter@netplus.ch
M. Suter
Department of Visceral Surgery, CHUV,
Lausanne, Switzerland
of cholecystokinin, resulting in poor gallbladder emptying,
and thereby altering the entero-hepatic circulation of biliary
salts [2, 8, 12, 13]. These mechanisms also contribute to a
higher risk of developing gallstones after bariatric surgery.
Because of the high prevalence of gallstone disease in
morbidly obese patients and the high risk to develop
gallstones during rapid weight loss after bariatric surgery,
we decided to perform routine prophylactic cholecystec-
tomy in our morbidly obese patients undergoing RYGBP,
provided the intraoperative findings did not preclude a
safe dissection. In this paper, we report the results of this
policy with respect to safety, pre- and intraoperative
findings, and histological findings, and discuss whether
routine prophylactic cholecystectomy is justified during
laparoscopic RYGBP.
Patients and Methods
Patients with a bodymass index (BMI) in excess of 40 kg/m2,
or >35 kg/m2 with at least one severe comorbidity, were
offered laparoscopic Roux-en-Y gastric bypass after failure
of conservative treatment and complete evaluation by a
multidisciplinary team. Contraindications were according to
the consensus development conference panel of the
National Institute of Health and to the consensus on obesity
treatment in Switzerland [14, 15].
Preoperative evaluation included, among others, upper
gastrointestinal endoscopy and abdominal echography in all
patients. The aim of the latter was to assess the size of the
liver and to detect gallbladder stones. Gastroscopy was
used to exclude gastro-duodenal lesions before Roux-en-Y
gastric bypass and to detect Helicobacter pylori infection so
as to eradicate it before surgery.
Our general policy was to offer concomitant cholecystec-
tomy at the time of laparoscopic RYGBP to all patients. The
presence of gallstones, symptomatic or not, was the reason in
those in whom these were detected preoperatively by
echography. In the remaining patients, the high incidence of
gallstone formation after RYGBP, as reported in the
literature, and the potential for long-term stone-related
complications, was given as the reason for prophylactic
cholecystectomy. No patient refused cholecystectomy. The
patients were explained, however, that cholecystectomy
would only be performed if the surgeon considered it safe
at the end of the RYGBP in regards to local and general
conditions of the patient.
Since the introduction of laparoscopic bariatric surgery
in our department in December 1995, a prospective
computerized bariatric database has been created, including
preoperative patient’s demographic and anthropometric
data, comorbidities, operative and follow-up data. All
patients undergoing laparoscopic RYGBP between January
2000 and August 2007 were included in this series. The
charts of those operated between 2000 and 2004 were
reviewed in details for data regarding the results of
preoperative echography and histological examination of
the gallbladder.
All patients were given prophylactic antibiotics (amoxicil-
line-clavulanate 2.2 g, or ciprofloxacine 200 mg and
metronidazole 500 mg for those allergic to penicillin)
intravenously at the induction of anesthesia. Prophylaxis
against thromboembolism was started either the evening
before surgery or at the induction of anesthesia using low-
molecular-weight heparin at a dose that was adapted to the
patient’s body weight and pursued until the end of the second
postoperative week. The surgical technique used for RYGBP
included six trocars and has been described in details
elsewhere [16]. After completion of gastric bypass and in the
absence of any major intraoperative complication, the right
upper quadrant was assessed for the feasibility of cholecys-
tectomy. If exposurewas deemed sufficient, and in the absence
of severe adhesions surrounding the gallbladder, cholecystec-
tomy was performed using the same trocars and instruments
used for the primary procedure. No additional trocar was
placed. Dissection of the gallbladder was performed using the
Ultracision 10 mm (Ethicon Endo-surgery, 8957 Spreitenbah,
Switzerland). No intraoperative cholangiography was per-
formed. The gallbladder was delivered from the abdominal
cavity through the 15-mm trocar incision, usually after
transparietal puncture and aspiration of the bile. At the end of
the procedure, a Jackson–Pratt drain was placed in the vicinity
of the gastrojejunostomy, and a Penrose drain was left in the
15-mm trocar incision.
Results
A total of 772 patients underwent laparoscopic RYGBP as a
primary bariatric procedure in our department between
January 2000 and August 2007. There were 186 men and
586 women with a mean age of 39.8 years (extremes 18–66).
The mean preoperative weight was 126.2 kg (86–227), and
the mean BMI was 45.6 kg/m2 (34–73.4). Fifty-eight (7.5%)
of these patients had undergone prior cholecystectomy and
were excluded from further analysis. In the remaining 714
patients, preoperative echography disclosed gallbladder
stones in 81 patients (10.5%), and a small polyp of the
gallbladder in one patient.
Cholecystectomywas performed at the time of laparoscopic
RYGBP in 655 (91.7%) of these 714 patients. The indication
was asymptomatic gallstones in 79 patients and routine
prophylaxis of postoperative cholelithiasis in the others.
Among the latter patients, with normal preoperative findings
on transabdominal echography, 25 (3.9% false negative
findings) were found to have gallstones intraoperatively. The
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total prevalence of gallstones in the entire series was therefore
21.2%. Cholecystectomy was not performed in two patients
with known asymptomatic cholelithiasis because exposure in
the right upper quadrant was considered insufficient. In the
remaining 54 patients, poor visibility was the reason for not
performing cholecystectomy in 47 patients and liver cirrhosis
discovered at surgery in four. Three patients, who were
Jehovah witnesses, were not submitted to cholecystectomy to
avoid any associated risk of hemorrhage. Patients who did not
undergo cholecystectomy at the time of surgery were
prescribed ursodesoxycholic acid orally for 6 months.
The mean age of patients with gallstones at RYGBP or a
history of prior cholecystectomy was significantly greater
than that of patients without gallstones (43.5 versus
38.7 years, p<0,0001, t test). There was no difference
between the two groups regarding preoperative weight,
BMI, or waist circumference. Patients who underwent
concomitant cholecystectomy at the time of laparoscopic
RYGBP were younger (38.9 versus 44.6 years, p<0,0001,
t test), had a slightly lower BMI (45.4 versus 46.7 kg/m2,
p=0.04, t test), and a lower weight (125.4 versus 130.9 kg,
p=0.01, t test) than those in whom cholecystectomy was
not performed. The mean overall duration of surgery was
significantly shorter in patients with concurrent cholecys-
tectomy than in the remaining ones (142.6 versus
158.6 min, p=0.0001, t test). This mostly reflects the
greater overall technical difficulties encountered during the
performance of gastric bypass in patients in whom
cholecystectomy was deemed too risky. In a consecutive
group of 100 patients, the additional time required for
cholecystectomy was monitored and found to be 19 min
(5–45min). Cholecystectomywas associated with no specific
morbidity, except for one accidental puncture of the junction
of the cystic duct and the common bile duct by a clip in a
patient with gallstones. The latter was immediately closed
with a single stitch without any short- or long-term
consequence. There was no difference in the duration of
hospital stay between patients with and without concomitant
cholecystectomy (median 4 days in both groups).
Between 2000 and 2004, 351 patients underwent
prophylactic cholecystectomy during laparoscopic RYGBP,
257 women and 94 men, with a mean age of 41.1 years
(19–60 years). Their mean BMI was 45.7, similar to that of
the whole series. Twenty-eight patients had had prior
cholecystectomy, and cholecystectomy was deemed risky
and therefore not performed during RYGBP in 38 patients.
Cholecystectomy was therefore performed during RYGBP
in 285 patients. In those who still had their gallbladder in
place, preoperative echography showed stones in 54
patients (17%). The gallbladder could not be visualized on
preoperative ultrasound examination in five patients (1.6%)
because of technical difficulties. Table 1 shows the findings
of the pathological examination of the gallbladder in this
group. The latter was totally normal in only 52 (18.2%)
patients. The most common findings were chronic chole-
cystitis in 180 patients (63.8%), followed by cholesterolosis
in 144 (51%). There was no relationship between histolog-
ical findings and age or BMI. Gallstones (5:4) and
cholesterolosis (4:3) were more common in women, whereas
chronic cholecystitis was more prevalent in men (7:6).
Discussion
Our results show that almost routine cholecystectomy at the
time of laparoscopic RYGBP is very safe, that echography
can be misleading, and that the vast majority of gallblad-
ders in morbidly obese patients show histopathological
abnormalities.
According to the literature, the prevalence of gallstones
in morbidly obese patients varies between 19 and 45%
[1, 4, 6, 8, 9, 13, 18, 19], and up to 25% of patients have
undergone cholecystectomy before bariatric surgery. Our
results grossly fall within these ranges. Dittrick et al. [19]
compared gallbladder histopathological findings in 478
morbidly obese patients with a control group of 481 liver
donors. Seventy-two percent had abnormal findings at
histological examination in the obese group, compared
with 21% in the liver donors. Liem and Niloff [18] found
abnormalities in 75% of gallbladders routinely removed in
141 patients and Aidonopoulos 97% in 64 patients. In 761
patients undergoing RYGBP reported by Fobi et al. [8], the
incidence of gallbladder pathology was 86.2%.
Rapid weight loss after bariatric surgery is associated
with an even greater risk to develop gallstones than obesity
per se. Deitel and Petrov [20] reported an 11.5% incidence
after bariatric surgery, and Kamrath et al. [21] noted 10.3%
symptomatic gallstones with a very low calorie diet.
Shiffman et al. [12] reported that 49% of 81 patients
developed gallstones or sludge within 6–18 months of
RYGBP, 28% of them requiring cholecystectomy. Schmidt
et al. [6] found that 40% had developed cholelithiasis
and/or required cholecystectomy after RYGBP. Amaral and
Table 1 Results of histopathological examination of the gallbladder
Type of lesion Number (%) Sex ratio
Chronic cholecystitis (CC) 180 (63.8) 133/47
Cholesterolosis 144 (51.0) 116/28
CC + cholesterolosis 94 (33.3) 73/21
Unknown gallstones 11 (3.9) 6/5
Cholesterol polyp 2 (0.7) 0/2
Metaplasia 3 (1.0) 2/1
Dysplasia 1 (0.3) 0/1
Adenomyosis 1 (0.3) 1/0
Total abnormal 230 (81.6) 156/73
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Thompson [10] reported a 27.6% incidence of complications
related to gallstones after bariatric surgery, including com-
mon duct stones and pancreatitis. Some form of prophylaxis
seems therefore warranted. A survey of members of the
ASBS totaling more than 8,000 patients showed that 40% still
had their gallbladder after the bariatric procedure and were,
therefore, at risk to develop gallstones [1].
Another way to prevent gallstones after bariatric surgery
is chemoprophylaxis with ursodeoxycholic acid (UDA)
during rapid weight loss. In a randomized study, Sugerman
et al. [22] showed that a 6-month course of this drug was
superior to placebo (2 vs 32%). UDA is also effective with
low-calorie diet [23]. Compliance may be limited, but the
drug has been shown to be cost-effective [24, 25].
Recently, routine prophylactic cholecystectomy during
RYGBP has been challenged by several authors, arguing
that the risks might outweigh the benefit, but also because
newer studies reported a much lower incidence of gall-
stones, especially symptomatic ones. Hamad et al. [17]
found that in a group of 94 patients, cholecystectomy
during laparoscopic RYGBP prolonged surgery by more
than an hour and hospital stay by more than 1 day. Our
results are not in accordance with the above regarding
duration of surgery and hospital stay. Another group
recently found simultaneous cholecystectomy to prolong
surgery by a mean of 29 min, with no effect on hospital
stay [26], and Villegas et al. [27] reported the additional
operative time devoted to cholecystectomy to be 20 min,
very similar to ours. In the same series, 45% of the patients
without cholecystectomy were found to have developed
gallstones or sludge within 6 months of RYGBP, but only
one fourth of these patients (7.3% of the total) developed
stone-related symptoms including cholangitis and septic
shock. Patients compliant with drug prevention developed
fewer stones. In the study of Hamad et al. [17], only eight
patients (2.3%) who did not undergo cholecystectomy
developed symptomatic stones during a 12-month follow-
up. Another group recently reported on a large group of
RYGBP patients without prophylaxis, of whom 8.1%
developed gallstone-related symptoms and eventually re-
quired cholecystectomy. Both authors concluded that the
incidence of symptomatic gallstones was low and that
routine cholecystectomy was probably not mandatory [28].
Clearly, rapid weight loss after RYGBP is associated
with a markedly increased prevalence of gallstones and
gallbladder histopathological abnormalities, which may
predispose to gallstones. The advantage of routine prophy-
lactic cholecystectomy in RYGBP patients is that it reduces
to zero the risk to develop gallbladder stones and their
possible complications. This must be balanced with the
risks associated with cholecystectomy. Laparoscopic cho-
lecystectomy is safe in obese patients [29–31]. In patients
undergoing laparoscopic RYGBP, placement of the trocars
is not ideal for cholecystectomy and may make it more
difficult. In our series, however, cholecystectomy, when
attempted, could always be completed without complication.
Cholecystectomy has been associated with a variety of
postoperative gastrointestinal symptoms, with major
changes reported in up to 12% of patients [32–34]. Results
from different studies, however, are inconsistent. Severe
diarrhea is extremely rare after cholecystectomy. The fear to
cause post-cholecystectomy symptoms should not be a
reason for avoiding cholecystectomy during RYGBP.
In conclusion, the incidence of gallbladder pathology is
high. Without any form of prophylaxis, gallstones develop
in a significant number of patients after RYGBP, and there
seems to be a consensus on the need for prevention. We can
recommend prophylactic cholecystectomy as a safe method
in the majority of patients, provided exposure of the
gallbladder area is sufficient. In the remaining patients, a
6-month course of ursodeoxycholic acid at 600 mg daily
seems adequate. Only a large prospective randomized trial
comparing cholecystectomy at the time of RYGBP with a
6-month pharmacological prevention will answer the
question as to which method is superior for gallstone
prophylaxis after RYGBP.
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